Effectiveness of Partial-body Cryotherapy on the Fatigue of Patients With Multiple Sclerosis During Readaptation Stay

CompletedNot a drug-phase studyMS (type not specified)NCT05219201

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

This trial finished 2 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • partial-body cryotherapy chamber session

What it measured

Main measures

  • Fatigue syndrome

    change from baseline (T0) to discharge between 3 to 5 weeks (T1), and 1 month (T2), 3 months (T3) and 1 year (T4) after hospitalization

    Fatigue

Other measures (9)

  • spasticity symptom

    change from baseline (T0) to discharge between 3 to 5 weeks (T1), and 1 year (T4) after hospitalization

    Spasticity
  • quality of Life evaluation

    change from baseline (T0) to discharge between 3 to 5 weeks(T1), and 1 month (T2), 3 months (T3) and 1 year (T4) after hospitalization

    Quality of life (reported by participants)
  • pain evaluation

    change from baseline (T0) to discharge between 3 to 5 weeks(T1), and 1 month (T2), 3 months (T3) and 1 year (T4) after hospitalization

    Pain
  • quality of sleep

    change from baseline (T0) to discharge between 3 to 5 weeks(T1), after 1 month (T2), 3 months (T3) and 1 year (T4)

    Mood and sleep
  • depression symptoms

    change from baseline (T0) to discharge between 3 to 5 weeks(T1), and 1 month (T2), 3 months (T3) and 1 year (T4) after hospitalization

    Mood and sleep
  • physician's global assessment-physical endurance

    change from baseline (T0) to discharge between 3 to 5 weeks (T1), and 1 year (T4) after hospitalization

    Walking and mobility
  • habit changes after rehabilitation stay

    change from baseline (T0) to 1 month (T2), 3 months (T3) and 1 year (T4) after hospitalization

  • physician's global assessment-dynamic balance test

    change from baseline (T0) to discharge between 3 to 5 weeks (T1), and 1 year (T4) after hospitalization

    Walking and mobility
  • physician's global assessement-static balance test

    change from baseline (T0) to discharge between 3 to 5 weeks (T1), and 1 year (T4) after hospitalization

    Walking and mobility

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* men and woen over 18 years old and under 65 years old * with multiple sclerosis * 0-6 points in the expanded disability states scale (EDSS) * with MS in remission (at least 6 months since the last relapse) * able to understand and respect the protocol and its requirement * who signed the consent prior to any other procedure protocol

Exclusion criteria

* major patients under guardianship/curators/legal protection * pregnant patients * patients with contraindication for cryotherapy * patients unable to complete the entire program * patients with substantial change in pharmacological treatment the month before the start of the study

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

the aim of the study is to evaluate the effectiveness of partial-body cryotherapy (PBC) on the symptoms of patients with multiple sclerosis during a rehabilitation stay.

Papers

Loading reviews and guidelines…

History

    1. Started

      Sept 2022

    2. Main results due

      Jun 2024

    3. Finished

      Jul 2025

    Assembled by software from public sources.